Skip to main content

Aflac Value Stock - Dividend - Research Selection

Aflac

ISIN: US0010551028 , WKN: 853081

Market price date:
Market price:  


Fundamental data and company key figures of the share

Annual reports in
Key figures
Cash flow
Net operating cash flow
Capital Expenditures
Free cash flow
Balance sheet
Total Equity
Liabilities & Shareholders equity
Income statement
Net income
Eps (diluted)
Diluted shares outstanding
Net sales/revenue

Fundamental ratios calculated on:

Ratios
Key figures
Cash flow
P/C
 
P/FC
Balance sheet
ROI
ROE
Income statement
P/E
Div. Yield %
P/B
P/S


Do you want to do make a detailed fundamental analysis of this stock?

✓ NEW Fundamental API Access to 500 data points per month
Fundamental data up to 25 years
Comparison to all other stocks by the FScore
Time saving!

How our site works ...

Non-binding 7 days without automatic subscription
 No termination required after the free week
Finanzoo fundamental analysis
Data updated daily
Virtual depots
Share alarms via email
Subscription can be canceled at any time at the end of the month 
Choice of desired shares
Over 2000 stock analyzes available
Bitcoin payment possible if you do not want to subscribe

Price for monthly subscription $ 19.99 / month including VAT.



Description Data
Symbol
Market Capitalization USD
Country
Indices
Sectors
Raw Data Source
Stock Split
Internet


Description of the company

General Description

Aflac Incorporated (the Parent Company) was incorporated in 1973 under the laws of the state of Georgia. Aflac Incorporated is a general business holding company and acts as a management company, overseeing the operations of its subsidiaries by providing management services and making capital available. Its principal business is voluntary supplemental and life insurance, which is marketed and administered through its subsidiary, American Family Life Assurance Company of Columbus (Aflac), which operates in the United States (Aflac U.S.) and as a branch in Japan (Aflac Japan). Most of Aflac's policies are individually underwritten and marketed through independent agents. Aflac U.S. markets and administers group products through Continental American Insurance Company (CAIC), branded as Aflac Group Insurance. Our insurance operations in the United States and our branch in Japan service the two markets for our insurance business.

 

On December 2, 2016, we publicly announced that we will pursue the conversion of Aflac Japan from a branch structure to a subsidiary structure, with the subsidiary incorporated as a “Kabushiki Kaisha.” While the branch structure remains an acceptable legal form, the subsidiary structure has emerged as the more prevalent structure for both domestic and foreign companies operating in Japan. In addition, emerging global regulatory standards generally favor the subsidiary structure for foreign insurance and financial service companies. The adoption of this new organizational framework is expected to be tax-neutral and not to have a material impact on the daily operations of either Aflac Japan or Aflac U.S. as a result of this conversion. In addition, we expect to obtain enhanced flexibility in capital management and business development as a result of the conversion. We anticipate completion of the conversion in mid-2018.

 

Aflac offers voluntary insurance policies in Japan and the United States that provide a layer of financial protection against income and asset loss. We continue to diversify our product offerings in both Japan and the United States. Aflac Japan sells voluntary supplemental insurance products, including cancer plans, general medical indemnity plans, medical/sickness riders, care plans, living benefit life plans, ordinary life insurance plans and annuities. Aflac U.S. sells voluntary supplemental insurance products including products designed to protect individuals from depletion of assets (accident, cancer, critical illness/care, hospital indemnity, fixed-benefit dental, and vision care plans) and loss-of-income products (life and short-term disability plans).

 

We are authorized to conduct insurance business in all 50 states, the District of Columbia, several U.S. territories and Japan. Aflac Japan's revenues, including realized gains and losses on its investment portfolio, accounted for 71% of the Company's total revenues in 2016, compared with 70% in 2015 and 72% in 2014. The percentage of the Company's total assets attributable to Aflac Japan was 83% at both December 31, 2016 and 2015.

 

Reporting Segments

Aflac's insurance business consists of two reporting segments: Aflac Japan and Aflac U.S. Aflac Japan, which currently operates as a branch of Aflac, is the principal contributor to the Parent Company’s consolidated earnings. The conversion of Aflac Japan to a subsidiary structure is not expected to affect our segment reporting structure.

 

For information on our results of operations and financial information by segment, see MD&A and Note 2 of the Notes to the Consolidated Financial Statements in this report.

The Finanzoo GmbH assumes no liability for the accuracy of the information! All information is provided without warranty. Sources:: www.bundesanzeiger.de, www.sec.gov,


NEWS


TD Cowen Maintains Aflac (AFL) Hold Recommendation

2025-12-22

Will Aflac's (AFL) Ethos Partnership Recast Its Digital Distribution and Supplemental Health Narrative?

2025-12-21
Ethos recently announced a partnership with Aflac Incorporated, making Aflac’s supplemental cancer insurance available on Ethos’s fully digital life insurance platform to provide rapid, low-friction access to cash benefits for cancer-related costs. This collaboration highlights how Aflac is using third-party technology distribution to widen reach for its supplemental health products and embed coverage directly into modern digital insurance journeys. We’ll now examine how embedding Aflac’s...

Aflac updates June 2025 security incident

2025-12-19
Aflac appreciates our customers' patience as we have worked diligently to respond to and address the security incident within our U.S. business that we initially disclosed in June 2025.

Mizuho Initiates Coverage on Aflac (AFL) with Cautious Outlook Citing Stagnant Sales Growth

2025-12-19
Aflac Incorporated (NYSE:AFL) is one of the most profitable value stocks to invest in right now. On December 16, Mizuho initiated coverage of Aflac with an Underperform rating and $104 price target. Mizuho maintains a cautious outlook on Aflac’s sales performance in its key Japanese and US markets. The firm believes that stagnant sales growth […]

Aflac Expands Digital Reach via Ethos Tie-Up in Supplemental Health

2025-12-19
AFL partners with Ethos to sell cancer insurance on a fully digital platform, letting customers add supplemental coverage in minutes alongside life policies.

Ethos and Aflac Partner to Bring Supplemental Health Product Suite to Independent Distribution

2025-12-18
AUSTIN, Texas, Dec. 18, 2025 (GLOBE NEWSWIRE) -- Ethos, a leading life insurance technology company democratizing access to life insurance, today announced a partnership with Aflac Incorporated (NYSE: AFL), a leading provider of supplemental health insurance in the U.S., to expand access to Aflac’s supplemental insurance policies through Ethos’s digital distribution platform. The collaboration launches with Aflac’s cancer insurance, now available alongside Ethos’s life insurance offerings, expan

Top Analyst Reports for Alphabet, Tesla & Sony

2025-12-17
Alphabet leads Zacks' top analyst reports, with Tesla and Sony also featured as new research highlights ahead of Wall Street.

Assessing Aflac Stock After Strong Multi Year Rally and Capital Return Momentum

2025-12-17
Wondering if Aflac at around $109 a share is still a smart buy or if most of the upside is already priced in? You are not alone, and that is exactly what this breakdown is here to unpack. The stock is up 1.4% over the last week and 7.0% year to date, but that momentum comes after a 4.2% pullback over the last month that tempers what has still been a powerful 65.6% 3 year and 185.8% 5 year run. Recent headlines have focused on Aflac's continued capital returns via steady share repurchases and...

Assessing Aflac’s Valuation After Its Recent 4% Pullback (AFL)

2025-12-17
Aflac (AFL) has slipped about 4% over the past month even though its year to date return is still positive, which sets up an interesting question for investors about whether this pullback offers value. See our latest analysis for Aflac. That recent 4% one month share price pullback comes after a steady climb that has left Aflac with a solid year to date share price return and an especially strong multi year total shareholder return. This suggests that momentum is moderating rather than...

How Recent Analyst Upgrades Are Shaping The Story Behind Aflac’s Valuation

2025-12-17
Updated Fair Value Narrative for Aflac Aflac's fair value estimate has been nudged down only slightly, from $111.38 to $111.08 per share, even as recent research notes remain broadly constructive on the insurer's long term earnings power. This minor adjustment reflects a tension between solid fundamentals, including resilient earnings and disciplined capital deployment, and lingering macro and sector uncertainties that temper enthusiasm at the margin. Readers should stay tuned to understand...